|
1
|
Shi L, Cheng Z, Zhang J, Li R, Zhao P, Fu
Z and You Y: hsa-mir-181a and hsa-mir-181b function as tumor
suppressors in human glioma cells. Brain Res. 1236:185–193. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang Y, Wang X, Zhang J, Sun G, Luo H,
Kang C, Pu P, Jiang T, Liu N and You Y: MicroRNAs involved in the
EGFR/PTEN/AKT pathway in gliomas. J Neurooncol. 106:217–224. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu N, Chen NY, Cui RX, Li WF, Li Y, Wei
RR, Zhang MY, Sun Y, Huang BJ, Chen M, et al: Prognostic value of a
microRNA signature in nasopharyngeal carcinoma: a microRNA
expression analysis. Lancet Oncol. 13:633–641. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li T, Chen JX, Fu XP, Yang S, Zhang Z,
Chen K-H and Li Y: microRNA expression profiling of nasopharyngeal
carcinoma. Oncol Rep. 25:1353–1363. 2011.PubMed/NCBI
|
|
5
|
Chen SJ, Chen GH, Chen YH, Liu CY, Chang
KP, Chang YS and Chen HC: Characterization of Epstein-Barr virus
miRNAome in nasopharyngeal carcinoma by deep sequencing. PLoS One.
5:pii. e127452010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wong TS, Man OY, Tsang CM, Tsao SW, Tsang
RK, Chan JY, Ho WK, Wei WI and To VS: MicroRNA let-7 suppresses
nasopharyngeal carcinoma cells proliferation through downregulating
c-Myc expression. J Cancer Res Clin Oncol. 137:415–422. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Carbon S, Ireland A, Mungall CJ, Shu S,
Marshall B and Lewis S: AmiGO: online access to ontology and
annotation data. Bioinformatics. 25:288–289. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim SJ, Shin JY, Lee KD, Bae YK, Sung KW,
Nam SJ and Chun KH: MicroRNA let-7a suppresses breast cancer cell
migration and invasion through downregulation of C-C chemokine
receptor type 7. Breast Cancer Res. 14:R142012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu Y, Yin B, Zhang C, Zhou L and Fan J:
Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma
cell lines by targeting c-myc. Biochem Biophys Res Commun.
417:371–375. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang Q, Jie Z, Cao H, Greenlee AR, Yang C,
Zou F and Jiang Y: Low-level expression of let-7a in gastric cancer
and its involvement in tumorigenesis by targeting RAB40C.
Carcinogenesis. 32:713–722. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Y, Lu Y, Toh ST, Sung WK, Tan P, Chow
P, Chung AY, Jooi LL and Lee CG: Lethal-7 is down-regulated by the
hepatitis B virus x protein and targets signal transducer and
activator of transcription 3. J Hepatol. 53:57–66. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Richly H, Aloia L and Di Croce L: Roles of
the Polycomb group proteins in stem cells and cancer. Cell Death
Dis. 2:e2042011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Margueron R and Reinberg D: The Polycomb
complex PRC2 and its mark in life. Nature. 469:343–349. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chang CJ and Hung MC: The role of EZH2 in
tumour progression. Br J Cancer. 106:243–247. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiao Y: Enhancer of zeste homolog 2: a
potential target for tumor therapy. Int J Biochem Cell Biol.
43:474–477. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Simon JA and Lange CA: Roles of the EZH2
histone methyltransferase in cancer epigenetics. Mutat Res.
647:21–29. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shin YJ and Kim JH: The role of EZH2 in
the regulation of the activity of matrix metalloproteinases in
prostate cancer cells. PLoS One. 7:e303932012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ntziachristos P, Tsirigos A, Van
Vlierberghe P, Nedjic J, Trimarchi T, Flaherty MS, Ferres-Marco D,
da Ros V, Tang Z, Siegle J, et al: Genetic inactivation of the
polycomb repressive complex 2 in T cell acute lymphoblastic
leukemia. Nat Med. 18:298–301. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang C, Liu Z, Woo CW, Li Z, Wang L, Wei
JS, Marquez VE, Bates SE, Jin Q, Khan J, et al: EZH2 Mediates
epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU,
RUNX3, and NGFR. Cancer Res. 72:315–324. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huqun, Ishikawa R, Zhang J, Miyazawa H,
Goto Y, Shimizu Y, Hagiwara K and Koyama N: Enhancer of zeste
homolog 2 is a novel prognostic biomarker in nonsmall cell lung
cancer. Cancer. 118:1599–1606. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hwang CF, Huang HY, Chen CH, Chien CY, Hsu
YC, Li CF and Fang FM: Enhancer of zeste homolog 2 overexpression
in nasopharyngeal carcinoma: an independent poor prognosticator
that enhances cell growth. Int J Radiat Oncol Biol Phys.
82:597–604. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tong ZT, Cai MY, Wang XG, Kong LL, Mai SJ,
Liu YH, Zhang HB, Liao YJ, Zheng F, Zhu W, et al: EZH2 supports
nasopharyngeal carcinoma cell aggressiveness by forming a
co-repressor complex with HDAC1/HDAC2 and Snail to inhibit
E-cadherin. Oncogene. 31:583–594. 2012.PubMed/NCBI
|
|
24
|
Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH,
Chen SP, Bian XW, Guan XY, Lin MC, Zeng YX, et al: The putative
tumour suppressor microRNA-124 modulates hepatocellular carcinoma
cell aggressiveness by repressing ROCK2 and EZH2. Gut. 61:278–289.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu X, Wang C, Chen Z, Jin Y, Wang Y,
Kolokythas A, Dai Y and Zhou X: MicroRNA-138 suppresses
epithelial-mesenchymal transition in squamous cell carcinoma cell
lines. Biochem J. 440:23–31. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Juan AH, Kumar RM, Marx JG, Young RA and
Sartorelli V: Mir-214-dependent regulation of the polycomb protein
Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell.
36:61–74. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lu J, He ML, Wang L, Chen Y, Liu X, Dong
Q, Chen YC, Peng Y, Yao KT, Kung HF and Li XP: MiR-26a inhibits
cell growth and tumorigenesis of nasopharyngeal carcinoma through
repression of EZH2. Cancer Res. 71:225–233. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Alajez NM, Shi W, Hui AB, Bruce J,
Lenarduzzi M, Ito E, Yue S, O’Sullivan B and Liu FF: Enhancer of
Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal
carcinoma and is regulated by miR-26a, miR-101, and miR-98. Cell
Death Dis. 1:e852010. View Article : Google Scholar : PubMed/NCBI
|
